GSK faces growing opposition to US parallel trade policy

October 27, 2003

GlaxoSmithKline is facing growing opposition from US patient groups and politicians to its attempt to block cheap drug imports from …

Milburn shortlists 50 hospitals for foundation status

October 27, 2003

Health Secretary Alan Milburn has shortlisted 50 hospitals he believes are ready to take on foundation status before the next …

AstraZeneca painkiller collaboration fails

October 27, 2003

The future of a potential new blockbuster pain killer under development by AstraZeneca is in doubt after it failed safety …

Lilly and Sankyo to share sales team

October 27, 2003

Eli Lilly and Sankyo Pharma UK are to share sales representatives in an innovative new arrangement co-ordinated by contract sales …

NHS promotes primary care drug dictionary

October 27, 2003

A campaign to raise PCT awareness of the new Primary Care Drug Dictionary (PCCD) has been launched to promote its …

Canada first market for Crestor

October 27, 2003

AstraZeneca's Crestor is to receive an immediate launch in its first market after Canada's regulator's approved the new cholesterol lowering …

Mixed Paxil patent news for GSK

October 27, 2003

GlaxoSmithKline has received mixed news in the on-going patent battle with Canadian generics company Apotex over its biggest selling drug, …

Pfizer blockbuster to face competition

October 27, 2003

Pfizer's blockbuster hypertension and angina treatment Norvasc could face competition from a related drug following a US court ruling.A ruling …

Private sector invited to take over failing hospitals

October 27, 2003

The poorest performing NHS hospitals could now be run by private companies under new plans unveiled by the Government.Eight private …

NICE launches intervention assessment programme

October 27, 2003

The safety and efficacy of new surgical and non-surgical interventions are to be assessed as part of a new NICE …

Galen boosted by $295m Sarafem purchase

October 27, 2003

Galen has bolstered its product range by buying the rights to pre-menstrual syndrome treatment Sarafem from Lilly for $295 million.Shares …

ReNeuron in merger talks

October 24, 2003

Industry wins parallel import trademark case

October 24, 2003

A new UK High Court ruling has given pharma companies the right to block the sale of re-packaged parallel imports …

Three companies face US fraud lawsuits

October 24, 2003

Three pharmaceutical companies, GlaxoSmithKline, Pharmacia and Aventis, face legal action for alleged bribery and inflation of prescription drug prices in …

The Gateway to Local Adoption Series

Latest content